Emergent BioSolutions reported a $191.3 million non-cash impairment charge on its NARCAN asset group, resulting in a GAAP net loss of $180.2 million for the quarter ended June 30, 2026. The company also lowered its full-year revenue guidance by about 10.8%, citing increased competition affecting its outlook and asset value. Following this announcement, Emergent's stock price plunged nearly 30%. Pomerantz LLP has launched an investigation into whether Emergent and its executives engaged in securities fraud or other unlawful practices, potentially leading to a class action lawsuit.
Emergent BioSolutions is the subject of an investor alert regarding a legal investigation. For readers following the health sector, here is Pluang's market snapshot as of Sep 17, 2026 21:11 WIB: out of 91 priced US health stocks, 59 rose and 31 fell. Notable movers include RXRX at USD 3.37 with a 5.64% increase and 100% buy order activity, ILMN at USD 241.64 with a 5.55% rise and 97% sell order activity, and DNA at USD 7.44 with a 5.38% gain.
Fluence Energy's stock price target was cut sharply from $15.00 to $4.00 by RBC Capital analyst Christopher Dendrinos after the company slashed its 2026 revenue forecast from $3.00 billion to $2.40 billion. The company now expects an adjusted EBITDA ...
Regency Centers reported solid Q2 2026 results with Funds From Operations (FFO) at $1.21 per share and a 3.8% growth in same-property Net Operating Income (NOI). The company raised its full-year guidance, signaling confidence in continued growth. Reg...
Ciena reported a 37% revenue increase to $1.67 billion and a 215% rise in adjusted EPS to $2.11 in its fiscal third quarter, driven by strong demand from AI and cloud infrastructure. The company is well positioned to benefit from the AI networking ma...
Maureen Gellerman, Chief Human Resources Officer at Five Below, sold 1,610 shares of the company, generating $401,000 from the transaction. This insider sale may indicate personal financial planning or portfolio rebalancing but does not necessarily r...
ON Semiconductor is focusing on advanced power-density technologies for AI data centers and electric vehicles, aiming for $2.5 billion revenue from AI alone by 2030. Despite a Neutral rating from UBS, the company introduced its Embedded Power Platfor...
